MARKET

ACOG

ACOG

Alpha Cognition
NASDAQ
5.95
+0.46
+8.38%
Closed 16:04 05/13 EDT
OPEN
5.53
PREV CLOSE
5.49
HIGH
5.95
LOW
5.33
VOLUME
45.90K
TURNOVER
12.23K
52 WEEK HIGH
11.54
52 WEEK LOW
4.500
MARKET CAP
129.55M
P/E (TTM)
-5.0893
1D
5D
1M
3M
1Y
5Y
1D
Craig-Hallum Sticks to Its Buy Rating for Alpha Cognition Inc (ACOG)
TipRanks · 1d ago
Weekly Report: what happened at ACOG last week (0504-0508)?
Weekly Report · 3d ago
Weekly Report: what happened at ACOG last week (0427-0501)?
Weekly Report · 05/04 10:24
Alpha Cognition amends 8-K, names Bethany Sensenig audit committee chair
PUBT · 05/01 20:41
Alpha Cognition to report quarterly results, host conference call after market close
PUBT · 04/28 20:55
Alpha Cognition (Nasdaq: ACOG) to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, May 14, 2026
Barchart · 04/28 15:30
Alpha Cognition CEO to join H.C. Wainwright BioConnect investor conference
PUBT · 04/27 12:05
Alpha Cognition Price Target Maintained With a $18.00/Share by HC Wainwright & Co.
Dow Jones · 04/27 11:23
More
About ACOG
Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer’s disease and Cognitive Impairment with mild Traumatic Brain Injury (mTBI). The Company's ZUNVEYL (benzgalantamine) product is a delayed release oral tablet formulation indicated for the treatment of mild to moderate dementia of the Alzheimer’s type in adults. Its pre-clinical development programs include ZUNVEYL in combination with memantine for the treatment of moderate-to-severe Alzheimer’s disease; ALPHA-1062 sublingual formulation; ALPHA-1062 intranasal formulation for the treatment of cognitive impairment with mTBI; ALPHA-0602; ALPHA-0702 & ALPHA-0802 (Progranulin and Progranulin GEM’s) for the treatment of neurodegenerative diseases including amyotrophic lateral sclerosis or Lou Gehrig’s disease and spinal muscular atrophy, and ALPHA-1062 for the treatment of acute pancreatitis.

Webull offers Alpha Cognition Inc stock information, including NASDAQ: ACOG real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ACOG stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ACOG stock methods without spending real money on the virtual paper trading platform.